Market Access for MedTech
Unlocking Patient Access to MedTech Innovations.
We strive to help you answer the fundamental questions: WHO PAYS for your health technology ? And WHY?
For that, we propose tailored market access stategies that helps optimize payment and adoption strategies, improve patient access to your innovations and achieve your business goals.
Partner with us to navigate the complexities of emerging & developped markets, crafting the value of your innovations that resonates with the 4Ps: Patients, Payers, Providers and Policy-makers.
Whether you are a healthcare company or start-up with access challenges for your Medical Devices, Digital Health solutions or Diagnostics technologies, we can help. We bring extensive experience and professionalism to every case and customize our support to your individual needs and concerns.
Contact Us
PO Box #452798
Dubai, United Arab Emirates
contact@has4p.com
Expertises
Reimbursement
Develop robust reimbursement strategies, tailored to your specific health technology (medical device, digital health, diagnostics…). We navigate complex reimbursement systems, ensuring optimal pricing, coding, and coverage to facilitate market entry and maximize product uptake.
Value Proposition
In order to convince payers and decision-makers to pay and adopt your technology, it is critical to define well the value proposition of the product. We can help you craft the unique benefits and differentiation of your technology that resonate to Patients, Payers, Providers, Policy-makers for Access and Adoption.
Policy Shaping &
Stakeholder Engagement
Policies play a major role in facilitating access and funding decisions. How can we engage with the key stakeholders of the ecosystem to drive advocacy and access? How to anticipate and shape policies that could enable better patient access to innovations? We help you engage with payers, policy-makers, patients and providers (hospitals, clinics, healthcare professionals…) to ensure they understand the value of your technology. We facilitate productive dialogues, shape policies and advocate for favorable market access conditions, collaborating with key stakeholders, payers and policymakers to influence decision-making.
Evidence Generation Strategy
What evidence would be needed to then demonstrate the value proposition of your technology? What do Payers or Health Technology Assessment agencies want in your reimbursement submission? We identify the most appropriate evidence generation strategy for your technology, clarifying which clinical and/or economic studies are necessary, and which ones are nice-to-have.
Get in Touch
Do tell us about your access challenge, and we can discuss how to solve it.